ArticleMolecular cancer therapeutics2020

Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer.

Jinge Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.